No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
MY Stock MarketDetailed Quotes
7139 NICE
- 0.165
- 0.0000.00%
15min DelayMarket Closed Dec 20 16:50 CST
189.58MMarket Cap-20.63P/E (TTM)
0.165High0.160Low2.89MVolume0.165Open0.165Pre Close470.00KTurnover0.20552wk High0.45%Turnover Ratio1.15BShares0.10052wk Low-0.008EPS TTM106.99MFloat Cap6.000Historical HighLossP/E (Static)648.45MShs Float0.020Historical Low-0.011EPS LYR3.03%Amplitude--Dividend TTM2.32P/B100Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Fennec Pharmaceuticals Brief: Announcing Pedmarqsi "Positive Recommendation" by NICE for Prevention of Cisplatin-Induced Hearing Loss in England and Wales
Fennec Pharmaceuticals Announces Pedmarqsi Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
NICE Shares Fall After Downgrade From Jefferies
NICE Cut to Hold From Buy by Jefferies
NICE Price Target Cut to $200.00/Share From $215.00 by Jefferies
NICE Ltd. (NICE) Powers Fulton Bank's AI-Driven Customer Service